betaine has been researched along with Disease Models, Animal in 87 studies
glycine betaine : The amino acid betaine derived from glycine.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Excerpt | Relevance | Reference |
---|---|---|
"Betaine inhibits colonic oxidative stress induced inflammatory pyroptosis to alleviate ASUC, which shows therapeutic potential against colitis and other acute inflammatory disorder." | 8.12 | Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory Pyroptosis. ( Cao, W; Chen, L; Liang, Y; Liu, D; Liu, W; Mao, M; Wang, Y; Zhong, X, 2022) |
"Betaine is known to act against various biological stresses and its levels were reported to be decreased in schizophrenia patients." | 7.91 | Investigation of betaine as a novel psychotherapeutic for schizophrenia. ( Balan, S; Esaki, K; Fujita, Y; Hashimoto, K; Hayashi-Takagi, A; Hino, M; Hisano, Y; Iwayama, Y; Kakita, A; Kunii, Y; Maekawa, M; Mataga, N; Matsumoto, J; Nagaoka, A; Nozaki, Y; Ohba, H; Ohnishi, T; Shimamoto-Mitsuyama, C; Tan, Y; Toyoshima, M; Watanabe, A; Yabe, H; Yoshikawa, T, 2019) |
"Alcohol-induced hyperhomocysteinemia has been reported in rats and humans." | 7.72 | Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. ( Ji, C; Kaplowitz, N, 2003) |
"Betaine is a natural compound that exerts beneficial anti-inflammatory effects." | 5.72 | Betaine supplementation alleviates dextran sulfate sodium-induced colitis ( Chen, C; Cui, J; He, Y; Hu, Y; Jing, T; Liu, E; Wang, S; Xu, H; Yang, Y; Zhao, N, 2022) |
"Betaine treatment restored normal spermine and spermidine levels but further increased 5'-methylthioadenosine." | 5.62 | Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis. ( Jiang, H; Maclean, KN; Mclagan, BM; Phinney, WN; Roede, JR; Stabler, SP, 2021) |
"Betaine attenuated MCD diet-induced NAFLD by reducing fat accumulation and inhibiting hepatocyte proliferation." | 5.48 | The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease. ( Jorgačević, B; Labudović-Borović, M; Mladenović, D; Radosavljević, T; Rakočević, J; Vesković, M; Vučević, D; Zaletel, I, 2018) |
"Betaine was intravitreally injected in OIR mice at postnatal day (P) 14." | 5.46 | Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. ( Jun, HO; Kang, BC; Kim, JH; Kwon, E; Park, SW; Park, YJ; Yun, JW, 2017) |
"Early diagnosis of hepatocellular carcinoma (HCC) remains challenging to date." | 5.42 | Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients. ( Hu, C; Huang, X; Lin, X; Niu, J; Tan, Y; Wang, H; Wang, X; Yin, P; Zeng, J; Zhou, L, 2015) |
" Our findings are consistent with a relatively sharp threshold effect between severely elevated plasma homocysteine and thrombotic risk in HCU and indicate that the HO mouse model can serve as a useful tool for both testing novel treatment strategies and examining the optimal timing and dosing of betaine treatment with a view toward optimizing clinical outcome." | 5.38 | Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. ( Allen, RH; Greiner, LS; Jiang, H; Maclean, KN; Stabler, SP, 2012) |
"Betaine has a lipotropic effect, which is associated with a reduction in homocysteine, an increase in ApoA-I and an amelioration of the atherogenic risk profile." | 5.34 | Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. ( Cohn, J; Jiang, H; Maclean, KN; Mikael, LG; Rozen, R; Schwahn, BC; Wang, XL; Wu, Q, 2007) |
"Betaine inhibits colonic oxidative stress induced inflammatory pyroptosis to alleviate ASUC, which shows therapeutic potential against colitis and other acute inflammatory disorder." | 4.12 | Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory Pyroptosis. ( Cao, W; Chen, L; Liang, Y; Liu, D; Liu, W; Mao, M; Wang, Y; Zhong, X, 2022) |
"Abnormally high levels of homocysteine (Hcy) are associated with autism spectrum disorder." | 3.91 | Betaine ameliorates prenatal valproic-acid-induced autism-like behavioral abnormalities in mice by promoting homocysteine metabolism. ( Chen, X; Chen, Z; Cui, C; Huang, F; Jiang, X; Niu, J; Sun, J, 2019) |
"Betaine is known to act against various biological stresses and its levels were reported to be decreased in schizophrenia patients." | 3.91 | Investigation of betaine as a novel psychotherapeutic for schizophrenia. ( Balan, S; Esaki, K; Fujita, Y; Hashimoto, K; Hayashi-Takagi, A; Hino, M; Hisano, Y; Iwayama, Y; Kakita, A; Kunii, Y; Maekawa, M; Mataga, N; Matsumoto, J; Nagaoka, A; Nozaki, Y; Ohba, H; Ohnishi, T; Shimamoto-Mitsuyama, C; Tan, Y; Toyoshima, M; Watanabe, A; Yabe, H; Yoshikawa, T, 2019) |
"We have shown previously that in ovo betaine injection can prevent nonalcoholic fatty liver induced by glucocorticoid exposure in chickens; yet it remains unknown whether feeding betaine to laying hens may exert similar effects in their progeny." | 3.88 | Corticosterone-Induced Lipogenesis Activation and Lipophagy Inhibition in Chicken Liver Are Alleviated by Maternal Betaine Supplementation. ( Abobaker, H; Hou, Z; Hu, Y; Omer, NA; Sun, Q; Zhao, R; Zong, Y, 2018) |
"Topical application of betaine, L-carnitine, or erythritol systematically limited progression of environmentally induced dry eye." | 3.79 | Efficacy of osmoprotectants on prevention and treatment of murine dry eye. ( Chen, Q; Chen, W; Garrett, Q; Hou, C; Li, J; Wang, Y; Zhang, X, 2013) |
"Hyperhomocysteinemia (Hhcy) may induce memory deficits with β-amyloid (Aβ) accumulation and tau hyperphosphorylation." | 3.79 | Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. ( Chai, GS; Cheng, XS; Jiang, X; Liu, GP; Ma, ZW; Ni, ZF; Wang, JZ; Wang, Q; Xie, AJ, 2013) |
"Betaine could inhibit the development of atherosclerosis via anti-inflammation." | 3.74 | [Anti-atherosclerotic effect of betaine in apolipoprotein E-deficient mice]. ( DU, YP; Fan, RX; Hou, MJ; Lü, SW; Zhu, HL, 2008) |
"Alcohol-induced hyperhomocysteinemia has been reported in rats and humans." | 3.72 | Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. ( Ji, C; Kaplowitz, N, 2003) |
"Betaine is a significant determinant of plasma tHcy, particularly in case of folate deficiency, methionine load, or alcohol consumption." | 2.49 | The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. ( Obeid, R, 2013) |
"In the pathophysiology of Alzheimer's disease, the deposition of amyloid β peptide (Aβ) is associated with oxidative stress, leading to cognitive impairment and neurodegeneration." | 1.72 | Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus. ( Hiramatsu, M; Ibi, D; Kojima, Y; Kondo, S; Nakasai, G; Ohmi, A; Takaba, R, 2022) |
"Betaine is a natural compound that exerts beneficial anti-inflammatory effects." | 1.72 | Betaine supplementation alleviates dextran sulfate sodium-induced colitis ( Chen, C; Cui, J; He, Y; Hu, Y; Jing, T; Liu, E; Wang, S; Xu, H; Yang, Y; Zhao, N, 2022) |
"Betaine treatment restored normal spermine and spermidine levels but further increased 5'-methylthioadenosine." | 1.62 | Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis. ( Jiang, H; Maclean, KN; Mclagan, BM; Phinney, WN; Roede, JR; Stabler, SP, 2021) |
"Non-alcoholic fatty liver disease (NAFLD) is a common disease with a multitude of complications." | 1.62 | Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis. ( Huang, T; Jia, M; Li, Y; Liu, S; Luo, Z; Miao, W; Song, Z; Wang, P; Wu, T; Yu, J; Yu, L; Zhang, H; Zhou, L, 2021) |
"Nonalcoholic fatty liver disease (NAFLD) represents a hepatic manifestation of metabolic syndrome." | 1.56 | Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine-Choline-Deficient Diet-Induced NAFLD. ( Jadžić, J; Jorgačević, B; Labudović-Borović, M; Mladenović, D; Radosavljević, T; Vesković, M; Vučević, D; Vukićević, D, 2020) |
"Male Sprague‑Dawley rats with induced dry eye disease were randomly assigned to four groups: Vehicle (control), low‑dose goji berry extract [GBE; 250 mg/kg/body weight (bw)], median‑dose GBE (350 mg/kg/bw), and high‑dose GBE (500 mg/kg/bw)." | 1.48 | Effects of Lycium barbarum (goji berry) on dry eye disease in rats. ( Chen, FA; Chien, KJ; Horng, CT; Hsieh, YH; Huang, YS; Lu, CC; Wang, CJ; Yang, JS, 2018) |
"Betaine attenuated MCD diet-induced NAFLD by reducing fat accumulation and inhibiting hepatocyte proliferation." | 1.48 | The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease. ( Jorgačević, B; Labudović-Borović, M; Mladenović, D; Radosavljević, T; Rakočević, J; Vesković, M; Vučević, D; Zaletel, I, 2018) |
"Betaine is a derivative of the amino acid glycine widely investigated for its hepatoprotective properties against alcoholism." | 1.48 | Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury. ( Ahmadi, A; Azarpira, N; Farshad, O; Ghanbarinejad, V; Heidari, R; Hosseini, A; Jamshidzadeh, A; Khodaei, F; Mohammadi, H; Najibi, A; Niknahad, H; Ommati, MM; Rashidi, E; Sadeghi, A; Siavashpour, A, 2018) |
"Betaine was intravitreally injected in OIR mice at postnatal day (P) 14." | 1.46 | Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. ( Jun, HO; Kang, BC; Kim, JH; Kwon, E; Park, SW; Park, YJ; Yun, JW, 2017) |
"Thirty-nine deep partial thickness wounds were created with six wounds assigned to one of six treatment groups: (i) PHMB, (ii) Ringer's solution, (iii) hypochlorous acid/sodium hypochlorite, (iv) sterile water, (v) octenidine dihydrochloride, and (vi) octenilin." | 1.46 | Effectiveness of a polyhexanide irrigation solution on methicillin-resistant Staphylococcus aureus biofilms in a porcine wound model. ( Davis, SC; Gil, J; Harding, A; Higa, A; Parajon, F; Solis, M; Valdes, J, 2017) |
"Betaine was administered orally (250 mg/kg) for a period of 21 days before burn injury, and single dose of betaine was administered after thermal injury." | 1.43 | Protective effect of betaine against burn-induced pulmonary injury in rats. ( Aykaç, A; Çetinel, Ş; Satılmış, B; Şehirli, AÖ; Şener, G; Tetik, Ş; Yeğen, B, 2016) |
"Betaine-treated Tg-I278T Cbs (-/-) mice also exhibited increased levels of betaine-dependent homocysteine methyl transferase (BHMT), increased levels of the lipogenic enzyme stearoyl-coenzyme A desaturase (SCD-1), and increased lipid droplet accumulation in the liver." | 1.43 | Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice. ( Gupta, S; Kruger, WD; Wang, L, 2016) |
"Betaine is a natural product that had been implicated in many biological processes and had been used for the therapy of some neurodegenerative disease, such as Alzheimer's disease." | 1.43 | Betaine reverses the memory impairments in a chronic cerebral hypoperfusion rat model. ( Nie, C; Nie, H; Wu, J; Zhang, X; Zhao, Y, 2016) |
"Choline is an essential nutrient, and its deficiency is related to PN-associated organ diseases." | 1.43 | Choline Alleviates Parenteral Nutrition-Associated Duodenal Motility Disorder in Infant Rats. ( Cai, W; Guo, Y; Huang, H; Lu, T; Tang, Q; Wu, Y; Zhu, J, 2016) |
"Early diagnosis of hepatocellular carcinoma (HCC) remains challenging to date." | 1.42 | Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients. ( Hu, C; Huang, X; Lin, X; Niu, J; Tan, Y; Wang, H; Wang, X; Yin, P; Zeng, J; Zhou, L, 2015) |
"Betaine treatment attenuated this increase in VEGF and HIF-1α expression via suppression of diabetes-induced Akt activation in the retinas of the diabetic rats." | 1.42 | Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats. ( Kim, CJ; Kim, YG; Lee, SH; Lim, HH; Shin, MS; Yang, HJ, 2015) |
"C31G has the potential to be used to treat herpetic keratitis as well as other herpetic topical lesions in humans." | 1.39 | The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model. ( Bhattacharjee, PS; Clement, C; Foster, TP; Hill, JM; Lukiw, WJ; Malamud, D; McFerrin, HE; Ochoa, AC; Rodriguez, P; Stern, EM; Velasco, C, 2013) |
" Our findings are consistent with a relatively sharp threshold effect between severely elevated plasma homocysteine and thrombotic risk in HCU and indicate that the HO mouse model can serve as a useful tool for both testing novel treatment strategies and examining the optimal timing and dosing of betaine treatment with a view toward optimizing clinical outcome." | 1.38 | Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. ( Allen, RH; Greiner, LS; Jiang, H; Maclean, KN; Stabler, SP, 2012) |
"Betaine was administered intragastrically after exposure of ethanol for 4 wk." | 1.36 | Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury. ( Gong, ZJ; Shi, QZ; Wang, LW; Zhang, W, 2010) |
"Betaine serves as a methyl donor in a reaction converting homocysteine to methionine." | 1.35 | Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. ( Du, Y; Fan, R; Hou, M; Ling, W; Lv, S; Tang, Z; Zhu, H, 2009) |
"Over 80% of chronic renal failure patients have elevated plasma Hcy and a 10-20 times higher incidence of vascular disease." | 1.34 | Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD). ( Chambers, S; Fraser, R; George, P; Lever, M; McEntyre, C; Slow, S; Vasudevamurthy, M, 2007) |
"Betaine has a lipotropic effect, which is associated with a reduction in homocysteine, an increase in ApoA-I and an amelioration of the atherogenic risk profile." | 1.34 | Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. ( Cohn, J; Jiang, H; Maclean, KN; Mikael, LG; Rozen, R; Schwahn, BC; Wang, XL; Wu, Q, 2007) |
"Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous)." | 1.34 | Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. ( Chen, T; Deaciuc, I; Hill, D; McClain, CJ; Song, M; Song, Z; Zhou, Z, 2007) |
" C31G was shown to be safe to both vaginal and rectal mucosal tissues and to the microflora with repeated daily use." | 1.33 | Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque. ( Balkus, JE; Hillier, SL; Patton, DL; Sweeney, YT, 2006) |
"Betaine was then intravenously administered at the same time as the methionine loading." | 1.32 | Effects of intravenous betaine on methionine-loading-induced plasma homocysteine elevation in rats. ( Nakata, R; Okawa, N; Shigematsu, N; Yagisawa, M, 2004) |
"Primary demyelination of these fibres was induced by sensitization of the animals to bovine cerebral white matter or myelin basic protein in complete Freund's adjuvant and challenge thereafter by intravitreous injection of basic protein (BP) or purified tuberculin (PPD)." | 1.25 | Experimental allergic optic neuritis (EAON) in the rabbit. A new model to study primary demyelinating diseases. ( Bloom, BR; Wiśniewski, HM, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.15) | 18.7374 |
1990's | 3 (3.45) | 18.2507 |
2000's | 17 (19.54) | 29.6817 |
2010's | 51 (58.62) | 24.3611 |
2020's | 15 (17.24) | 2.80 |
Authors | Studies |
---|---|
Solinski, HJ | 1 |
Dranchak, P | 1 |
Oliphant, E | 1 |
Gu, X | 1 |
Earnest, TW | 1 |
Braisted, J | 1 |
Inglese, J | 1 |
Hoon, MA | 1 |
Chen, ST | 1 |
Hsieh, CP | 1 |
Lee, MY | 1 |
Chen, LC | 1 |
Huang, CM | 1 |
Chen, HH | 1 |
Chan, MH | 1 |
Ibi, D | 2 |
Kondo, S | 2 |
Ohmi, A | 1 |
Kojima, Y | 2 |
Nakasai, G | 1 |
Takaba, R | 1 |
Hiramatsu, M | 2 |
Chen, L | 1 |
Liu, D | 1 |
Mao, M | 1 |
Liu, W | 1 |
Wang, Y | 3 |
Liang, Y | 1 |
Cao, W | 1 |
Zhong, X | 1 |
Zhao, N | 3 |
Yang, Y | 3 |
Chen, C | 3 |
Jing, T | 3 |
Hu, Y | 5 |
Xu, H | 3 |
Wang, S | 3 |
He, Y | 3 |
Liu, E | 3 |
Cui, J | 3 |
van Hummel, A | 1 |
Taleski, G | 1 |
Sontag, JM | 1 |
Feiten, AF | 1 |
Ke, YD | 1 |
Ittner, LM | 1 |
Sontag, E | 1 |
Jiang, YP | 1 |
Yang, JM | 2 |
Ye, RJ | 1 |
Liu, N | 1 |
Zhang, WJ | 1 |
Ma, L | 1 |
Zheng, P | 1 |
Niu, JG | 1 |
Liu, P | 1 |
Yu, JQ | 2 |
Vesković, M | 2 |
Labudović-Borović, M | 2 |
Mladenović, D | 2 |
Jadžić, J | 1 |
Jorgačević, B | 2 |
Vukićević, D | 1 |
Vučević, D | 2 |
Radosavljević, T | 2 |
Pourmehdi, A | 1 |
Sakhaei, Z | 1 |
Alirezaei, M | 1 |
Dezfoulian, O | 1 |
Zhang, T | 1 |
Lu, R | 1 |
Chen, Y | 1 |
Yuan, Y | 1 |
Song, S | 1 |
Yan, K | 1 |
Zha, Y | 1 |
Zhuang, W | 1 |
Cheng, Y | 1 |
Liang, J | 1 |
Chen, Q | 2 |
Jiao, F | 1 |
Shi, C | 1 |
Pei, M | 1 |
Wang, L | 2 |
Gong, Z | 1 |
Hirashima, K | 1 |
Sumiya, K | 1 |
Yamamoto, M | 1 |
Ando, T | 1 |
Maclean, KN | 5 |
Jiang, H | 5 |
Phinney, WN | 2 |
Mclagan, BM | 1 |
Roede, JR | 1 |
Stabler, SP | 4 |
Yoshihara, S | 1 |
Jiang, X | 4 |
Morikawa, M | 1 |
Ogawa, T | 1 |
Ichinose, S | 1 |
Yabe, H | 2 |
Kakita, A | 2 |
Toyoshima, M | 2 |
Kunii, Y | 2 |
Yoshikawa, T | 2 |
Tanaka, Y | 1 |
Hirokawa, N | 1 |
Lv, Y | 1 |
Ma, P | 2 |
Wang, J | 1 |
Xu, Q | 1 |
Fan, J | 1 |
Yan, L | 1 |
Zhou, R | 2 |
Huang, T | 1 |
Yu, J | 1 |
Luo, Z | 1 |
Yu, L | 1 |
Liu, S | 2 |
Wang, P | 1 |
Jia, M | 1 |
Wu, T | 1 |
Miao, W | 1 |
Zhou, L | 2 |
Song, Z | 4 |
Zhang, H | 1 |
Li, Y | 1 |
Chien, KJ | 1 |
Horng, CT | 1 |
Huang, YS | 1 |
Hsieh, YH | 1 |
Wang, CJ | 1 |
Yang, JS | 1 |
Lu, CC | 1 |
Chen, FA | 1 |
Zaletel, I | 1 |
Rakočević, J | 1 |
Sun, Q | 1 |
Hou, Z | 1 |
Zong, Y | 1 |
Omer, NA | 1 |
Abobaker, H | 1 |
Zhao, R | 1 |
Shiels, SM | 1 |
Bouchard, M | 1 |
Wang, H | 2 |
Wenke, JC | 1 |
Heidari, R | 1 |
Niknahad, H | 1 |
Sadeghi, A | 1 |
Mohammadi, H | 1 |
Ghanbarinejad, V | 1 |
Ommati, MM | 1 |
Hosseini, A | 1 |
Azarpira, N | 1 |
Khodaei, F | 1 |
Farshad, O | 1 |
Rashidi, E | 1 |
Siavashpour, A | 1 |
Najibi, A | 1 |
Ahmadi, A | 1 |
Jamshidzadeh, A | 1 |
Zhang, M | 1 |
Tan, HR | 1 |
Nanobashvili, K | 1 |
Jack-Roberts, C | 1 |
Bretter, R | 1 |
Jones, N | 1 |
Axen, K | 1 |
Saxena, A | 1 |
Blain, K | 1 |
Sánchez-López, E | 1 |
Kammeijer, GSM | 1 |
Crego, AL | 1 |
Marina, ML | 1 |
Ramautar, R | 1 |
Peters, DJM | 1 |
Mayboroda, OA | 1 |
Keating, AK | 1 |
Hurt, KJ | 1 |
Huang, F | 1 |
Chen, X | 1 |
Niu, J | 2 |
Cui, C | 1 |
Chen, Z | 2 |
Sun, J | 1 |
Gautam, A | 1 |
Muhie, S | 1 |
Chakraborty, N | 1 |
Hoke, A | 1 |
Donohue, D | 1 |
Miller, SA | 1 |
Hammamieh, R | 1 |
Jett, M | 1 |
Drobny, A | 1 |
Meloh, H | 1 |
Wächtershäuser, E | 1 |
Hellmann, B | 1 |
Mueller, AS | 1 |
van der Klis, JD | 1 |
Fitzenberger, E | 1 |
Wenzel, U | 1 |
Ohnishi, T | 1 |
Balan, S | 1 |
Maekawa, M | 1 |
Ohba, H | 1 |
Watanabe, A | 1 |
Iwayama, Y | 1 |
Fujita, Y | 1 |
Tan, Y | 2 |
Hisano, Y | 1 |
Shimamoto-Mitsuyama, C | 1 |
Nozaki, Y | 1 |
Esaki, K | 1 |
Nagaoka, A | 1 |
Matsumoto, J | 1 |
Hino, M | 1 |
Mataga, N | 1 |
Hayashi-Takagi, A | 1 |
Hashimoto, K | 1 |
de Castro, NM | 1 |
Yaqoob, P | 1 |
de la Fuente, M | 1 |
Baeza, I | 1 |
Claus, SP | 1 |
Strickland, FM | 1 |
Hewagama, A | 1 |
Wu, A | 1 |
Sawalha, AH | 1 |
Delaney, C | 1 |
Hoeltzel, MF | 1 |
Yung, R | 1 |
Johnson, K | 1 |
Mickelson, B | 1 |
Richardson, BC | 1 |
Jhong, JF | 1 |
Venault, A | 1 |
Hou, CC | 1 |
Chen, SH | 1 |
Wei, TC | 1 |
Zheng, J | 1 |
Huang, J | 1 |
Chang, Y | 1 |
Hill, JM | 1 |
Stern, EM | 1 |
Bhattacharjee, PS | 1 |
Malamud, D | 1 |
Clement, C | 1 |
Rodriguez, P | 1 |
Lukiw, WJ | 1 |
Ochoa, AC | 1 |
Foster, TP | 1 |
Velasco, C | 1 |
McFerrin, HE | 1 |
Chen, W | 1 |
Zhang, X | 3 |
Li, J | 2 |
Hou, C | 1 |
Garrett, Q | 1 |
Obeid, R | 1 |
Liu, YL | 1 |
Pan, Y | 1 |
Wang, X | 2 |
Fan, CY | 1 |
Zhu, Q | 1 |
Li, JM | 1 |
Wang, SJ | 1 |
Kong, LD | 1 |
Jadavji, NM | 1 |
Bahous, RH | 1 |
Deng, L | 1 |
Malysheva, O | 1 |
Grand'maison, M | 1 |
Bedell, BJ | 1 |
Caudill, MA | 1 |
Rozen, R | 3 |
Dou, X | 1 |
Xia, Y | 1 |
Chen, J | 1 |
Qian, Y | 1 |
Li, S | 1 |
Jinzenji, A | 1 |
Sogawa, C | 1 |
Miyawaki, T | 1 |
Wen, XF | 1 |
Yi, D | 1 |
Ohyama, K | 1 |
Kitayama, S | 1 |
Sogawa, N | 1 |
Morita, K | 1 |
Liu, H | 1 |
Gong, M | 1 |
French, BA | 1 |
Tillman, B | 1 |
French, SW | 1 |
Kim, YG | 1 |
Lim, HH | 1 |
Lee, SH | 1 |
Shin, MS | 1 |
Kim, CJ | 1 |
Yang, HJ | 1 |
Zhu, J | 1 |
Wu, Y | 1 |
Guo, Y | 1 |
Tang, Q | 1 |
Lu, T | 1 |
Cai, W | 1 |
Huang, H | 1 |
Imbard, A | 1 |
Benoist, JF | 1 |
Esse, R | 1 |
Gupta, S | 3 |
Lebon, S | 1 |
de Vriese, AS | 1 |
de Baulny, HO | 1 |
Kruger, W | 1 |
Schiff, M | 1 |
Blom, HJ | 1 |
Kruger, WD | 2 |
Zeng, J | 1 |
Huang, X | 1 |
Hu, C | 1 |
Lin, X | 1 |
Yin, P | 1 |
Nie, C | 1 |
Nie, H | 1 |
Zhao, Y | 1 |
Wu, J | 1 |
Kusat Ol, K | 1 |
Kanbak, G | 2 |
Oğlakcı Ilhan, A | 1 |
Burukoglu, D | 1 |
Yücel, F | 2 |
Salem, A | 1 |
Noaman, E | 1 |
Kandil, E | 1 |
Badawi, A | 1 |
Mostafa, N | 1 |
FitzGerald, PF | 1 |
Butts, MD | 1 |
Roberts, JC | 1 |
Colborn, RE | 1 |
Torres, AS | 1 |
Lee, BD | 1 |
Yeh, BM | 1 |
Bonitatibus, PJ | 1 |
Koeberl, DD | 1 |
Park, SW | 1 |
Jun, HO | 1 |
Kwon, E | 1 |
Yun, JW | 1 |
Kim, JH | 2 |
Park, YJ | 1 |
Kang, BC | 1 |
Şehirli, AÖ | 1 |
Satılmış, B | 1 |
Tetik, Ş | 1 |
Çetinel, Ş | 1 |
Yeğen, B | 1 |
Aykaç, A | 1 |
Şener, G | 1 |
Sogut, I | 1 |
Uysal, O | 1 |
Oglakci, A | 1 |
Kartkaya, K | 1 |
Davis, SC | 1 |
Harding, A | 1 |
Gil, J | 1 |
Parajon, F | 1 |
Valdes, J | 1 |
Solis, M | 1 |
Higa, A | 1 |
Fan, RX | 1 |
Lü, SW | 1 |
DU, YP | 1 |
Hou, MJ | 1 |
Zhu, HL | 1 |
Lv, S | 1 |
Fan, R | 1 |
Du, Y | 1 |
Hou, M | 1 |
Tang, Z | 1 |
Ling, W | 1 |
Zhu, H | 1 |
Kim, SH | 1 |
Yang, SO | 1 |
Kim, HS | 1 |
Kim, Y | 1 |
Park, T | 1 |
Choi, HK | 1 |
Shi, QZ | 1 |
Wang, LW | 1 |
Zhang, W | 1 |
Gong, ZJ | 1 |
Wetzel, KJ | 1 |
Bjorge, D | 1 |
Schwan, WR | 1 |
Cordero, P | 1 |
Campion, J | 1 |
Milagro, FI | 1 |
Martínez, JA | 1 |
Niebergall, LJ | 1 |
Jacobs, RL | 1 |
Chaba, T | 1 |
Vance, DE | 1 |
Greiner, LS | 1 |
Allen, RH | 2 |
Pilonieta, MC | 1 |
Nagy, TA | 1 |
Jorgensen, DR | 1 |
Detweiler, CS | 1 |
Medici, V | 1 |
Shibata, NM | 1 |
Kharbanda, KK | 3 |
LaSalle, JM | 1 |
Woods, R | 1 |
Engelberg, JA | 1 |
Devaraj, S | 1 |
Török, NJ | 1 |
Jiang, JX | 1 |
Havel, PJ | 1 |
Lönnerdal, B | 1 |
Kim, K | 1 |
Halsted, CH | 2 |
Chai, GS | 1 |
Ni, ZF | 1 |
Ma, ZW | 1 |
Xie, AJ | 1 |
Cheng, XS | 1 |
Wang, Q | 1 |
Wang, JZ | 1 |
Liu, GP | 1 |
Kawakami, S | 1 |
Han, KH | 1 |
Nakamura, Y | 1 |
Shimada, K | 1 |
Kitano, T | 1 |
Aritsuka, T | 1 |
Nagura, T | 1 |
Ohba, K | 1 |
Nakamura, K | 1 |
Fukushima, M | 1 |
Billington, CJ | 1 |
Schmidt, B | 1 |
Zhang, L | 1 |
Hodges, JS | 1 |
Georgieff, MK | 1 |
Schotta, G | 1 |
Gopalakrishnan, R | 1 |
Petryk, A | 1 |
Ji, C | 1 |
Kaplowitz, N | 2 |
Sleator, RD | 1 |
Francis, GA | 1 |
O'Beirne, D | 1 |
Gahan, CG | 1 |
Hill, C | 1 |
Schwahn, BC | 2 |
Laryea, MD | 1 |
Melnyk, S | 1 |
Pogribny, I | 1 |
Garrow, T | 1 |
James, SJ | 1 |
Yagisawa, M | 1 |
Okawa, N | 1 |
Shigematsu, N | 1 |
Nakata, R | 1 |
Rogers, DD | 1 |
Mailliard, ME | 1 |
Siford, GL | 1 |
Barak, AJ | 1 |
Beckenhauer, HC | 1 |
Sorrell, MF | 1 |
Tuma, DJ | 1 |
Patton, DL | 1 |
Sweeney, YT | 1 |
Balkus, JE | 1 |
Hillier, SL | 1 |
Slow, S | 1 |
Vasudevamurthy, M | 1 |
Fraser, R | 1 |
McEntyre, C | 1 |
Lever, M | 2 |
Chambers, S | 1 |
George, P | 1 |
Purohit, V | 1 |
Abdelmalek, MF | 1 |
Barve, S | 1 |
Benevenga, NJ | 1 |
Liu, QY | 1 |
Lu, SC | 1 |
McClain, CJ | 3 |
Swanson, C | 1 |
Zakhari, S | 1 |
Wang, XL | 1 |
Mikael, LG | 1 |
Wu, Q | 1 |
Cohn, J | 1 |
Deaciuc, I | 2 |
Zhou, Z | 2 |
Song, M | 1 |
Chen, T | 2 |
Hill, D | 1 |
Tarnow, P | 1 |
Jönsson, A | 1 |
Lindblom, L | 1 |
Gustafsson, T | 1 |
Cassuto, J | 1 |
Ogborn, MR | 1 |
Nitschmann, E | 1 |
Bankovic-Calic, N | 1 |
Buist, R | 1 |
Peeling, J | 1 |
Dellow, WJ | 1 |
Chambers, ST | 1 |
Barrell, GK | 1 |
Robson, RA | 1 |
Higashi, Y | 1 |
Yokogawa, K | 1 |
Takeuchi, N | 1 |
Tamai, I | 1 |
Nomura, M | 1 |
Hashimoto, N | 1 |
Hayakawa, JI | 1 |
Miyamoto, KI | 1 |
Tsuji, A | 1 |
Wiśniewski, HM | 1 |
Bloom, BR | 1 |
Hülsmann, WC | 1 |
Schneijdenberg, CT | 1 |
Verkleij, AJ | 1 |
Shatrov, VA | 1 |
Kruglova, IF | 1 |
Fal', EA | 1 |
Kadan, LP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus[NCT04302168] | 60 participants (Anticipated) | Interventional | 2020-04-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for betaine and Disease Models, Animal
Article | Year |
---|---|
The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway.
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Choline; Dietary Supplements; Disease Mo | 2013 |
The effect of dietary modulation of sulfur amino acids on cystathionine β synthase-deficient mice.
Topics: Acetylcysteine; Amino Acids, Sulfur; Animals; Betaine; Cystathionine beta-Synthase; Diet; Dietary Su | 2016 |
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.
Topics: Animals; Betaine; Disease Models, Animal; Folic Acid; Humans; Liver Diseases, Alcoholic; Methionine; | 2007 |
84 other studies available for betaine and Disease Models, Animal
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Betaine; Cognition; Disease Models, Animal; Disks L | 2021 |
Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Betaine; Cognitive Dysfunction; Disease Models, A | 2022 |
Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory Pyroptosis.
Topics: Animals; Betaine; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Huma | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Betaine supplementation alleviates dextran sulfate sodium-induced colitis
Topics: Animals; Anti-Inflammatory Agents; Betaine; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease M | 2022 |
Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy.
Topics: Alzheimer Disease; Animals; Betaine; Carbon; Choline; Dietary Supplements; Disease Models, Animal; F | 2023 |
Protective effects of betaine on diabetic induced disruption of the male mice blood-testis barrier by regulating oxidative stress-mediated p38 MAPK pathways.
Topics: Animals; Antioxidants; Betaine; Blood-Testis Barrier; Catalase; Diabetes Mellitus, Experimental; Dis | 2019 |
Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine-Choline-Deficient Diet-Induced NAFLD.
Topics: Animals; Betaine; Choline; Collagen; Diet; Dietary Supplements; Disease Models, Animal; Hepatocytes; | 2020 |
Betaine effects against asthma-induced oxidative stress in the liver and kidney of mice.
Topics: Animals; Antioxidants; Asthma; Betaine; Disease Models, Animal; Female; Glucocorticoids; Inflammatio | 2020 |
Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9.
Topics: Animals; Betaine; Body Weight; CRISPR-Cas Systems; Cystathionine beta-Synthase; Disease Models, Anim | 2020 |
Betaine inhibits Toll-like receptor 4 responses and restores intestinal microbiota in acute liver failure mice.
Topics: Animals; Bacteria; Betaine; Cell Line; Disease Models, Animal; Gastrointestinal Microbiome; Intestin | 2020 |
Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Betaine; Cognition; Cognitive Dysfunction; Diseas | 2021 |
Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
Topics: Adenosylhomocysteinase; Animals; Betaine; Cystathionine beta-Synthase; Disease Models, Animal; Folic | 2021 |
Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport.
Topics: Actins; Animals; Behavior, Animal; Betaine; Biological Transport; Diet; Disease Models, Animal; Gene | 2021 |
Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
Topics: Actins; Administration, Oral; Animals; Apoptosis; Arterioles; Betaine; Cardiotonic Agents; Disease M | 2021 |
Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis.
Topics: Animals; Betaine; Diet, High-Fat; Disease Models, Animal; Gene Expression Profiling; Lipid Metabolis | 2021 |
Effects of Lycium barbarum (goji berry) on dry eye disease in rats.
Topics: Animals; Betaine; Disease Models, Animal; Dry Eye Syndromes; Kidney; Liver; Lycium; Male; Plant Extr | 2018 |
The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease.
Topics: Animals; Betaine; Cell Nucleus; Cell Proliferation; Chromatin; Disease Models, Animal; Gastrointesti | 2018 |
Corticosterone-Induced Lipogenesis Activation and Lipophagy Inhibition in Chicken Liver Are Alleviated by Maternal Betaine Supplementation.
Topics: Animals; Betaine; Chickens; Corticosterone; Dietary Supplements; Disease Models, Animal; DNA Methyla | 2018 |
Chlorhexidine-releasing implant coating on intramedullary nail reduces infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Betaine; Bone and Bones; Bone Nails; Cefazolin; Chlorhexidine; Coate | 2018 |
Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury.
Topics: Acute Disease; Animals; Betaine; Bile Ducts; Biomarkers; Chronic Disease; Disease Models, Animal; Li | 2018 |
Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Betaine; Biomarkers; Chemokine CCL2; Cytokines; Di | 2018 |
Maternal Choline and Betaine Supplementation Modifies the Placental Response to Hyperglycemia in Mice and Human Trophoblasts.
Topics: Animal Feed; Animals; Betaine; Biomarkers; Blood Glucose; Cell Line, Tumor; Choline; Diabetes, Gesta | 2018 |
Sheathless CE-MS based metabolic profiling of kidney tissue section samples from a mouse model of Polycystic Kidney Disease.
Topics: Animals; Betaine; Carnitine; Creatine; Creatinine; Disease Models, Animal; Electrophoresis, Capillar | 2019 |
Taurine alleviates repression of betaine-homocysteine
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Disease Models, Animal; Homocystinuria; | 2019 |
Betaine ameliorates prenatal valproic-acid-induced autism-like behavioral abnormalities in mice by promoting homocysteine metabolism.
Topics: Animals; Antimanic Agents; Autism Spectrum Disorder; Behavior, Animal; Betaine; Disease Models, Anim | 2019 |
Metabolomic analyses reveal lipid abnormalities and hepatic dysfunction in non-human primate model for Yersinia pestis.
Topics: Animals; Betaine; Carnitine; Chlorocebus aethiops; Disease Models, Animal; Gas Chromatography-Mass S | 2018 |
Betaine-rich sugar beet molasses protects from homocysteine-induced reduction of survival in Caenorhabditis elegans.
Topics: Animals; Betaine; Caenorhabditis elegans; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; | 2020 |
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Topics: Animals; Betaine; Brain; Choline Dehydrogenase; Dietary Supplements; Disease Models, Animal; DNA Met | 2019 |
Premature impairment of methylation pathway and cardiac metabolic dysfunction in fa/fa obese Zucker rats.
Topics: Adipose Tissue, White; Age Factors; Animals; Betaine; Disease Models, Animal; Inositol; Liver; Magne | 2013 |
Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus.
Topics: Animals; Antibodies, Antinuclear; Betaine; CD40 Ligand; Choline; Coenzymes; Diet; Disease Models, An | 2013 |
Surface zwitterionization of expanded poly(tetrafluoroethylene) membranes via atmospheric plasma-induced polymerization for enhanced skin wound healing.
Topics: Adsorption; Animals; Bacterial Adhesion; Betaine; Biocompatible Materials; Blood Proteins; Cell Line | 2013 |
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.
Topics: Animals; Antiviral Agents; Betaine; Cornea; Disease Models, Animal; Fatty Acids, Unsaturated; Herpes | 2013 |
Efficacy of osmoprotectants on prevention and treatment of murine dry eye.
Topics: Animals; Apoptosis; Betaine; Carnitine; Cornea; Disease Models, Animal; Disease Progression; Dry Eye | 2013 |
Betaine reduces serum uric acid levels and improves kidney function in hyperuricemic mice.
Topics: Acetylglucosaminidase; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding | 2014 |
Mouse model for deficiency of methionine synthase reductase exhibits short-term memory impairment and disturbances in brain choline metabolism.
Topics: Acetylcholinesterase; Animals; Apoptosis; Betaine; Cerebellum; Choline; Choline O-Acetyltransferase; | 2014 |
Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Betaine; Cells, Cultured; Cytoprotection; Disease Models, Ani | 2014 |
Antiallodynic action of 1-(3-(9H-Carbazol-9-yl)-1-propyl)-4-(2-methyoxyphenyl)-4-piperidinol (NNC05-2090), a betaine/GABA transporter inhibitor.
Topics: Animals; Betaine; CHO Cells; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; G | 2014 |
Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).
Topics: Animals; Betaine; Blotting, Western; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; H | 2014 |
Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats.
Topics: Animals; Betaine; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoxia-In | 2015 |
Choline Alleviates Parenteral Nutrition-Associated Duodenal Motility Disorder in Infant Rats.
Topics: Animals; Animals, Newborn; Betaine; Choline; Disease Models, Animal; Duodenum; Gastrointestinal Moti | 2016 |
High homocysteine induces betaine depletion.
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Carrier Proteins; Disease Models, Animal | 2015 |
Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.
Topics: Animals; Betaine; Bone Density; Cystathionine beta-Synthase; Diet; Dietary Supplements; Disease Mode | 2016 |
Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients.
Topics: alpha-Fetoproteins; Animals; Betaine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cohort Studies; | 2015 |
Betaine reverses the memory impairments in a chronic cerebral hypoperfusion rat model.
Topics: Animals; Betaine; Brain; Chronic Disease; Dementia, Vascular; Disease Models, Animal; Disks Large Ho | 2016 |
The investigation of the prenatal and postnatal alcohol exposure-induced neurodegeneration in rat brain: protection by betaine and/or omega-3.
Topics: Animals; Betaine; Brain; Central Nervous System Depressants; Disease Models, Animal; Ethanol; Fatty | 2016 |
Crystal structure and chemotherapeutic efficacy of the novel compound, gallium tetrachloride betaine, against breast cancer using nanotechnology.
Topics: Animals; Apoptosis; Betaine; Crystallography, X-Ray; Disease Models, Animal; Drug Carriers; Female; | 2016 |
A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance.
Topics: Acute Kidney Injury; Animals; Betaine; Contrast Media; Disease Models, Animal; Kidney; Male; Nanopar | 2016 |
Vision of correction for classic homocystinuria.
Topics: Animals; Betaine; Cystathionine beta-Synthase; Disease Models, Animal; Homocystinuria; Humans; Mice; | 2016 |
Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Astrocytes; Betaine; Cell Movement; Cell Prolife | 2017 |
Protective effect of betaine against burn-induced pulmonary injury in rats.
Topics: Administration, Oral; Animals; Antioxidants; Betaine; Burns; Cytokines; Disease Models, Animal; Fema | 2016 |
Prenatal alcohol-induced neuroapoptosis in rat brain cerebral cortex: protective effect of folic acid and betaine.
Topics: Animals; Animals, Newborn; Apoptosis; Betaine; Blood Alcohol Content; Calpain; Caspase 3; Cathepsin | 2017 |
Effectiveness of a polyhexanide irrigation solution on methicillin-resistant Staphylococcus aureus biofilms in a porcine wound model.
Topics: Animals; Betaine; Biguanides; Biofilms; Disease Models, Animal; Disinfectants; Methicillin-Resistant | 2017 |
[Anti-atherosclerotic effect of betaine in apolipoprotein E-deficient mice].
Topics: Animals; Apolipoproteins E; Atherosclerosis; Betaine; Chemokine CCL2; Dietary Supplements; Disease M | 2008 |
Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Betaine; Chemokine CCL2; Dietary Supplements; Di | 2009 |
1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet.
Topics: Acetoacetates; Acetone; Animals; Betaine; Citric Acid; Dietary Fats; Disease Models, Animal; Glycine | 2009 |
Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Betaine; Biomarkers; Blotting, Western; | 2010 |
Mutational and transcriptional analyses of the Staphylococcus aureus low-affinity proline transporter OpuD during in vitro growth and infection of murine tissues.
Topics: Amino Acid Transport Systems, Neutral; Animals; Betaine; Disease Models, Animal; DNA Mutational Anal | 2011 |
Dietary supplementation with methyl donor groups could prevent nonalcoholic fatty liver.
Topics: Animals; Betaine; Choline; Dietary Fats; Dietary Sucrose; Dietary Supplements; Disease Models, Anima | 2011 |
Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis.
Topics: Adenoviridae; Animals; Betaine; Ceramides; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosph | 2011 |
Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Blood Coagulation; Cystathionine beta-Sy | 2012 |
A glycine betaine importer limits Salmonella stress resistance and tissue colonization by reducing trehalose production.
Topics: Animals; Betaine; Disease Models, Animal; Gene Deletion; Hydrogen Peroxide; Hydrogen-Ion Concentrati | 2012 |
Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.
Topics: Adolescent; Adult; Animals; Apolipoprotein A-I; Apolipoproteins A; Aryldialkylphosphatase; Betaine; | 2012 |
Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease.
Topics: Adenosylhomocysteinase; Animals; Betaine; Copper; Disease Models, Animal; DNA (Cytosine-5-)-Methyltr | 2013 |
Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine.
Topics: Alzheimer Disease; Animals; Betaine; Disease Models, Animal; Homocysteine; Hyperhomocysteinemia; Lip | 2013 |
Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse model.
Topics: Alanine Transaminase; Animals; Betaine; Body Weight; Diet, High-Fat; Dietary Fats; Dietary Supplemen | 2012 |
Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice.
Topics: Animals; Betaine; Choline; Craniofacial Abnormalities; Dietary Supplements; Disease Models, Animal; | 2013 |
Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice.
Topics: Animals; Betaine; Central Nervous System Depressants; Disease Models, Animal; Endoplasmic Reticulum; | 2003 |
Betaine and carnitine uptake systems in Listeria monocytogenes affect growth and survival in foods and during infection.
Topics: Animals; Betaine; Carnitine; Cryoprotective Agents; Disease Models, Animal; Food Microbiology; Human | 2003 |
Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency.
Topics: Animals; Animals, Suckling; Betaine; Body Weight; Brain; Disease Models, Animal; Female; Genotype; H | 2004 |
Effects of intravenous betaine on methionine-loading-induced plasma homocysteine elevation in rats.
Topics: Animals; Betaine; Disease Models, Animal; Glycine; Homocysteine; Hyperhomocysteinemia; Injections, I | 2004 |
A comparison of the effects of betaine and S-adenosylmethionine on ethanol-induced changes in methionine metabolism and steatosis in rat hepatocytes.
Topics: Animals; Betaine; Disease Models, Animal; Ethanol; Fatty Liver; Hepatocytes; Male; Methionine; Methy | 2005 |
Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque.
Topics: Administration, Intravaginal; Administration, Rectal; Animals; Anti-Infective Agents, Local; Betaine | 2006 |
Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD).
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Dialysis Solutions; Disease Models, Anim | 2007 |
Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia.
Topics: Animals; Animals, Genetically Modified; Aorta; Apolipoprotein A-I; Betaine; Cholesterol; Disease Mod | 2007 |
Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Betaine; Cell Line; Dietary Carbohyd | 2007 |
Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease.
Topics: Adiponectin; Adipose Tissue; Animals; Betaine; Cystathionine beta-Synthase; Disease Models, Animal; | 2008 |
Topical D-myo-inositol-1,2,6-trisphosphate and hexylbetaine treatment reduces albumin extravasation in experimental rat skin burn injury.
Topics: Administration, Topical; Albumins; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Ster | 1998 |
Dietary betaine modifies hepatic metabolism but not renal injury in rat polycystic kidney disease.
Topics: Animals; Betaine; Diet; Dietary Supplements; Disease Models, Animal; Kidney; Liver; Magnetic Resonan | 2000 |
Glycine betaine excretion is not directly linked to plasma glucose concentrations in hyperglycaemia.
Topics: Animals; Betaine; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Model | 2001 |
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.
Topics: Animals; Betaine; Carnitine; Carrier Proteins; Disease Models, Animal; Fatty Acids; Infusions, Intra | 2001 |
Experimental allergic optic neuritis (EAON) in the rabbit. A new model to study primary demyelinating diseases.
Topics: Animals; Antigens; Betaine; Demyelinating Diseases; Disease Models, Animal; Epitopes; Freund's Adjuv | 1975 |
Accumulation and excretion of long-chain acylcarnitine by rat hearts; studies with aminocarnitine.
Topics: Animals; Betaine; Carnitine; Carnitine O-Palmitoyltransferase; Coronary Disease; Disease Models, Ani | 1991 |
[Immunostimulating effect of synthetic surface-active agents in experimental tuberculosis].
Topics: Adjuvants, Immunologic; Animals; Betaine; Cyclic N-Oxides; Detergents; Disease Models, Animal; Macro | 1990 |